Authors
Loading...
In vivo analysis shows β2 adrenergic receptor S-nitrosylation loss reduces myocardial infarct size, suggesting enhanced cardioprotective signaling.
Rosales et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: